Treatment resistance NMDA receptor pathway polygenic score is associated with brain glutamate in schizophrenia. (2023)
Attributed to:
MICA: STRATA - Schizophrenia: Treatment Resistance And Therapeutic Advances
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.schres.2023.08.020
PubMed Identifier: 37657282
Publication URI: http://europepmc.org/abstract/MED/37657282
Type: Journal Article/Review
Volume: 260
Parent Publication: Schizophrenia research
ISSN: 0920-9964